Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment

Peter A. Fasching, Katharina Heusinger, Lothar Haeberle, +14

BMC Cancer

Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection

Michael Schrauder, Reiner Strick, Rüdiger Schulz‐Wendtland, +15

PLoS ONE

Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients

Matthias W. Beckmann, Cosima Brucker, Volker Hanf, +9

Onkologie

On a dark-field signal generated by micrometer-sized calcifications in phase-contrast mammography

Thilo Michel, Jens Rieger, G. Anton, +17

Physics in Medicine and Biology

EngineeringOncologic ImagingMicroscopyPolycapillary OpticsX-ray Imaging +23

Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies

Peter A. Fasching, Falk C. Thiel, K. Nicolaisen-Murmann, +5

Supportive Care in Cancer

NursingFamily MedicineQuality Of LifeLife SatisfactionLife Assessment +7

Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients

Folkward G. Wiesner, A. Magener, Peter A. Fasching, +9

The Breast

Routine Clinical UsePrognostic BiomarkersBreast OncologyOncologyBreast Cancer Patients +8

Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer

Michael P. Lux, Claudia Rauh, Alexander Hein, +10

BMC Cancer

The role of genetic breast cancer susceptibility variants as prognostic factors

Peter A. Fasching, Paul D.P. Pharoah, Angela Cox, +71

Human Molecular Genetics

Lymphedema in breast cancer survivors: Assessment and information provision in a specialized breast unit

Hiba A. Bani, Peter A. Fasching, Michael P. Lux, +7

Patient Education and Counseling

NursingSpecialized Breast UnitBreast OncologyInformation ProvisionMedicine +6

BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients

Marius Wunderle, Lothar Häberle, Vivien M. Flesch, +17

Breast Cancer Research and Treatment

Breast OncologyBreast Cancer PatientsMedicinePathologyPathological Complete Response +7